PUBLICATION

From zebrafish to human: A comparative approach to elucidate the role of the thyroid hormone transporter MCT8 during brain development

Authors
Vancamp, P., Darras, V.M.
ID
ZDB-PUB-171204-15
Date
2017
Source
General and comparative endocrinology   265: 219-229 (Review)
Registered Authors
Darras, Veerle
Keywords
AHDS, Animal model, Brain development, MCT8, Thyroid hormone
MeSH Terms
  • Animals
  • Brain/embryology*
  • Brain/metabolism*
  • Humans
  • Mental Retardation, X-Linked/metabolism
  • Mental Retardation, X-Linked/pathology
  • Models, Biological
  • Monocarboxylic Acid Transporters/metabolism*
  • Muscle Hypotonia/metabolism
  • Muscle Hypotonia/pathology
  • Muscular Atrophy/metabolism
  • Muscular Atrophy/pathology
  • Thyroid Hormones/metabolism*
  • Zebrafish/metabolism*
PubMed
29183795 Full text @ Gen. Comp. Endocrinol.
Abstract
Monocarboxylate transporter 8 (MCT8) facilitates transmembrane transport of thyroid hormones (THs) ensuring their action on gene expression during vertebrate neurodevelopment. A loss of MCT8 in humans results in severe psychomotor deficits associated with the Allan-Herndon-Dudley Syndrome (AHDS). However, where and when exactly a lack of MCT8 causes the neurological manifestations remains unclear because of the varying expression pattern of MCT8 between specific brain regions and cells. Here, we elaborate on the animal models that have been generated to elucidate the mechanisms underlying MCT8-deficient brain development. The absence of a clear neurological phenotype in Mct8 knockout mice made it clear that a single species would not suffice. The evolutionary conservation of TH action on neurodevelopment as well as the components regulating TH signalling however offers the opportunity to answer different aspects of MCT8 function in brain development using different vertebrate species. Moreover, the plethora of tools for genome editing available today facilitates gene silencing in these animals as well. Studies in the recently generated mct8-deficient zebrafish and Mct8/Oatp1c1 double knockout mice have put forward the current paradigm of impaired TH uptake at the level of the blood-brain barrier during peri- and postnatal development as being the main pathophysiological mechanism of AHDS. RNAi vector-based, cell-specific induction of MCT8 knockdown in the chicken embryo points to an additional function of MCT8 at the level of the neural progenitors during early brain development. Future studies including also additional in vivo models like Xenopus or in vitro approaches such as induced pluripotent stem cells will continue to help unravelling the exact role of MCT8 in developmental events. In the end, this multispecies approach will lead to a unifying thesis regarding the cellular and molecular mechanisms responsible for the neurological phenotype in AHDS patients.
Genes / Markers
Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping